The company's board of directors today alloted 30,25,000, equity share of Re 1 each at a premium of Rs 569 per share in the name of TA FII Investors Ltd, Shilpa Medicare said in a filing to BSE.
This is pursuant to the resolution passed by the company's shareholders at the EGM held today, it added.
"Naresh Patwari has been co-opted as an additional (non-executive and non-independent) director of the company, being the nominee of TA FII Investors Ltd with effect from today...," it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content